Cargando…

Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition

Here we show that acute myeloid leukemia (AML) cells require the BRD9 subunit of the SWI/SNF chromatin remodeling complex to sustain MYC transcription, rapid cell proliferation, and a block in differentiation. Based on these observations, we derived small-molecule inhibitors of the BRD9 bromodomain,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hohmann, Anja F., Martin, Laetitia J., Minder, Jessica, Roe, Jae-Seok, Shi, Junwei, Steurer, Steffen, Bader, Gerd, McConnell, Darryl, Pearson, Mark, Gerstberger, Thomas, Gottschamel, Teresa, Thompson, Diane, Suzuki, Yutaka, Koegl, Manfred, Vakoc, Christopher R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990482/ https://www.ncbi.nlm.nih.gov/pubmed/27376689 http://dx.doi.org/10.1038/nchembio.2115

Ejemplares similares

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
por: Martin, Laetitia J., et al.
Publicado: (2016)

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)
por: Herrmann, Harald, et al.
Publicado: (2012)

The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer
por: Wang, Eric, et al.
Publicado: (2015)

Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
por: Zoppi, Vittoria, et al.
Publicado: (2018)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
por: Farnaby, William, et al.
Publicado: (2019)

Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
por: Brien, Gerard L, et al.
Publicado: (2018)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

A Step toward NRF2‐DNA Interaction Inhibitors by Fragment‐Based NMR Methods
por: Brüschweiler, Sven, et al.
Publicado: (2021)

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Pericole, Fernando Vieira, et al.
Publicado: (2019)

Targeting BRD4 in acute myeloid leukemia with partial tandem duplication of the MLL gene
por: Bill, Marius, et al.
Publicado: (2021)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

Bromodomain-containing subunits BRD1, BRD2, and BRD13 are required for proper functioning of SWI/SNF complexes in Arabidopsis
por: Jarończyk, Kamila, et al.
Publicado: (2021)

Inducible knock-out of BCL6 in lymphoma cells results in tumor stasis
por: Schlager, Stefanie, et al.
Publicado: (2020)

Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition
por: Chen, Chong, et al.
Publicado: (2013)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

tBRD-1 and tBRD-2 regulate expression of genes necessary for spermatid differentiation
por: Theofel, Ina, et al.
Publicado: (2017)

Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2023)

Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia
por: Baragaño Raneros, Aroa, et al.
Publicado: (2021)

Interrogating Histone Acetylation and BRD4 as Mitotic Bookmarks of Transcription
por: Behera, Vivek, et al.
Publicado: (2019)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
por: Liu, Yi, et al.
Publicado: (2023)

A High-Throughput Yeast Two-Hybrid Protocol to Determine Virus-Host Protein Interactions
por: Striebinger, Hannah, et al.
Publicado: (2013)

RIOK1 kinase activity is required for cell survival irrespective of MTAP status
por: Hörmann, Alexandra, et al.
Publicado: (2018)

Molecular dynamics simulations data of six compounds F3J-BRD4/CBP, EX1-BRD4/CBP, and E2T-BRD4/CBP
por: Wu, Shiliang, et al.
Publicado: (2021)

SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
por: Tzelepis, Konstantinos, et al.
Publicado: (2018)

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph(+) chronic myeloid leukemia
por: Peter, Barbara, et al.
Publicado: (2022)

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3 ‐ITD
por: Qian, Yu, et al.
Publicado: (2023)

Emerging Roles of BRD7 in Pathophysiology
por: Park, Sang Won, et al.
Publicado: (2020)

Supercharging BRD4 with NUT in carcinoma
por: Eagen, Kyle P., et al.
Publicado: (2021)

BRD2 Compartmentalizes the Accessible Genome
por: Xie, Liangqi, et al.
Publicado: (2022)

Brd4‐Brd2 isoform switching coordinates pluripotent exit and Smad2‐dependent lineage specification
por: Fernandez‐Alonso, Rosalia, et al.
Publicado: (2017)

Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations
por: Wang, Lifei, et al.
Publicado: (2022)

Cloning BRD4 long isoform into overexpression vectors for stable overexpression of BRD4-L in mammalian cells
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2022)

Evaluating the bromodomain protein BRD1 as a therapeutic target in rheumatoid arthritis
por: Klein, Kerstin, et al.
Publicado: (2018)

Oncogene interference through targeting of chromatin regulators
por: Roe, Jae-Seok, et al.
Publicado: (2013)

C/EBPα: critical at the origin of leukemic transformation
por: Roe, Jae-Seok, et al.
Publicado: (2014)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

TUNEL labeling with BrdUTP/anti-BrdUTP greatly underestimates the level of sperm DNA fragmentation in semen evaluation
por: Ribeiro, Sofia C., et al.
Publicado: (2017)

Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expression
por: Dai, Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tbajb69la4uu1bdllv9tc2jc8u